Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gait Characteristics Following a Fall

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2012 by Hadassah Medical Organization
Information provided by (Responsible Party):
Hadassah Medical Organization Identifier:
First received: June 28, 2012
Last updated: April 4, 2016
Last verified: June 2012

June 28, 2012
April 4, 2016
June 2012
June 2017   (final data collection date for primary outcome measure)
Gait kinematics
Joint angles, velocities and accelerations
Same as current
Complete list of historical versions of study NCT01631604 on Archive Site
Muscle activation patterns
Dynamic EMG of various muscles.
Same as current
Not Provided
Not Provided
Gait Characteristics Following a Fall
Quantification of Gait Parameters and Muscle Activation Patterns Following a Fall
The purpose of this study is to quantify the safety degree of the patient's gait, to detect the reason for the fall and quantify the biomechanical parameters related to fall. This study also aims to evaluate the effect of different rehabilitation treatments and their effect on the risk of falling.

In this study, patients suffering from motor disabilities as a result of orthopedic or neurologic impairments will be tested at the gait and motion laboratory. Each patient will be secured with a ceiling-mounted safety harness and will walk on the path wearing passive light-reflecting markers and surface electrodes. High-speed cameras will record the subject's movements and the markers will be tracked to produce data of joint angles, velocities and accelerations. Dynamic EMG will be recorded from various muscles.

During the examination, the gait of the subjects will be disturb by either (i) a visual or sound signal that requires the subject to stop immediately, or (ii) walking different terrains, or (iii) tying a string to the foot and pulling it shortly to induce a trip.

Not Provided
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Factorial Assignment
Primary Purpose: Treatment
  • Motor Impairments
  • Orthopaedic Injuries
  • Neurological Conditions
  • Device: Walking aids and devices
    Walking aids, e.g. braces, canes,orthoses, prosthetics, etc.
  • Drug: Muscle/nerve injection
    Injection to muscle or nerve
    Other Names:
    • Botulinum toxin
    • Marcaine
  • Procedure: Corrective surgery
    correction of spinal and bony deformities, muscle transfer, tendon elongation etc.
    Other Names:
    • Knee arthroscopy, meniscectomy and chondroplasty
    • Anterior cruciate ligament reconstruction
    • Knee replacement
    • Repair of femoral neck fracture
    • Repair of trochanteric fracture
    • Debridement of skin/muscle/bone/fracture
    • Knee arthroscopy repair of both menisci
    • Hip replacement
    • Repair of ankle fracture (bimalleolar type)
    • Lumbar spinal fusion
    • Low back intervertebral disc surgery
    • Repair of femoral shaft fracture
  • Other: Physical therapy treatment
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Not Provided
June 2017
June 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Individuals suffering from gait impairment following injury to the central or peripheral nervous system, as well as following orthopedic injuries. The subjects will be able to understand and independently sign a consent form.

Exclusion Criteria:

  • Subjects who are unable to understand and independently sign a consent form
  • Subjects who are wheelchair bound.
  • Pregnant women.
5 Years and older   (Child, Adult, Senior)
Contact: Sigal Portnoy, Ph.D. 97225844492
Not Provided
Not Provided
Not Provided
Hadassah Medical Organization
Hadassah Medical Organization
Not Provided
Not Provided
Hadassah Medical Organization
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP